Allergy and COVID-19 Vaccines

Clinical trial NCT05028257 · COMPLETED

Trial details

NCT number: NCT05028257
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anaphylactic Reaction Vaccine Reaction

Start date: 2021-09-15
Primary completion: 2023-05-22
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.